Cover Image
Market Research Report

Global Novel Drug Delivery Systems Market Insights, Forecast to 2025

Published by QYResearch Product code 910407
Published Content info 156 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Novel Drug Delivery Systems Market Insights, Forecast to 2025
Published: September 9, 2019 Content info: 156 Pages
Description

This report studies the global market size of Novel Drug Delivery Systems in key regions like North America, Europe, Asia Pacific, South America and the Middle East & Africa, focuses on the consumption of Novel Drug Delivery Systems in these regions.

This research report categorizes the global Novel Drug Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Novel Drug Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, channels and distributors.

In 2018, the global Novel Drug Delivery Systems market size was increased to 23728.57million US$ from 22421.84 million US$ in 2014, and it will reach 26582.04million US$ in 2025, growing at CAGR of 1.73% between 2019 and 2025.

The following manufacturers are covered in this report, with revenue, market share for each company:

Amgen

Teva

Roche

UCB (Union Chimique Belge)

Celgene

Merck

Gilead Sciences

Sanofi

Pfizer

Takeda

Bausch&Lomb

Samyang Biopharmaceuticals

Johnson & Johnson

TOLMAR

Astellas

AMAG Pharmaceuticals

AbbVie

Dr Reddy

AstraZeneca

Aspen

Acrotech Biopharma

TWi Pharmaceuticals

Novel Drug Delivery Systems market size by type:

Liposomes

PEGylated Proteins & Polypeptides

Polymer Nanoparticle

Protein-drug Conjugates

Other

Novel Drug Delivery Systems market size by Applications:

Hospitals & Clinic

Cancer Treatment Centers

Others

Novel Drug Delivery Systems market size by region

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Europe

Germany

France

UK

Italy

Russia

Rest of Europe

South America

Brazil

Rest of South America

Middle East & Africa

Middle East

Africa

Table of Contents

1 Study Coverage 1

  • 1.1 Novel Drug Delivery Systems Product Introduction 1
  • 1.2 Market Segments 2
  • 1.3 Key Manufacturers Covered 3
  • 1.4 Market by Type 4
    • 1.4.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type 4
    • 1.4.2 Liposomes 6
    • 1.4.3 PEGylated Proteins & Polypeptides 6
    • 1.4.4 Polymer Nanoparticle 7
    • 1.4.5 Protein-drug Conjugates 7
  • 1.5 Market by Application 8
    • 1.5.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Application 8
    • 1.5.2 Hospitals & Clinic 10
    • 1.5.3 Cancer Treatment Centers 10
  • 1.6 Study Objectives 11
  • 1.7 Years Considered 12

2 Executive Summary 13

  • 2.1 Global Novel Drug Delivery Systems Market Size 13
  • 2.2 Novel Drug Delivery Systems Growth Rate by Region 14

3 Breakdown Data by Manufacturer 17

  • 3.1 Novel Drug Delivery Systems Revenue by Manufacturer 17
    • 3.1.1 Novel Drug Delivery Systems Revenue by Manufacturer (2018-2019) 17
    • 3.1.2 Novel Drug Delivery Systems Revenue Share by Manufacturer (2018-2019) 18
  • 3.2 Global Market Concentration Ratio (CR5 and HHI) 20
  • 3.3 Novel Drug Delivery Systems Gross Margin by Manufacturer 20
  • 3.4 Novel Drug Delivery Systems Headquarters, Product Types 21
    • 3.4.1 Novel Drug Delivery Systems Manufacturers Headquarters and Established Date 21
    • 3.4.2 Manufacturers Novel Drug Delivery Systems Product Type 22
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 23

4 Breakdown Data by Type 25

  • 4.1 Global Novel Drug Delivery Systems Revenue by Type 25
  • 4.2 Global Novel Drug Delivery Systems Revenue Share by Type 25

5 Breakdown Data by Application 27

  • 5.1 Overview 27
  • 5.2 Global Novel Drug Delivery Systems Breakdown Data by Application 27

6 North America 29

  • 6.1 North America Novel Drug Delivery Systems by Country 29
    • 6.1.1 North America Novel Drug Delivery Systems Revenue by Country 29
    • 6.1.2 United States 31
    • 6.1.3 Canada 32
    • 6.1.4 Mexico 33
  • 6.2 North America Novel Drug Delivery Systems by Type 33
  • 6.3 North America Novel Drug Delivery Systems by Application 35

7 Europe 37

  • 7.1 Europe Novel Drug Delivery Systems by Country 37
    • 7.1.1 Europe Novel Drug Delivery Systems Revenue by Country 37
    • 7.1.2 Germany 39
    • 7.1.2 France 40
    • 7.1.4 UK 41
    • 7.1.5 Italy 42
    • 7.1.6 Russia 43
  • 7.2 Europe Novel Drug Delivery Systems by Type 43
  • 7.3 Europe Novel Drug Delivery Systems by Application 45

8 Asia Pacific 47

  • 8.1 Asia Pacific Novel Drug Delivery Systems by Country 47
    • 8.1.1 Asia Pacific Novel Drug Delivery Systems Revenue by Country 47
    • 8.1.2 China 49
    • 8.1.3 Japan 50
    • 8.1.4 Korea 51
    • 8.1.5 India 52
    • 8.1.7 Southeast Asia 53
  • 8.2 Asia Pacific Novel Drug Delivery Systems by Type 53
  • 8.3 Asia Pacific Novel Drug Delivery Systems by Application 54

9 South America 56

  • 9.1 South America Novel Drug Delivery Systems by Country 56
    • 9.1.1 South America Novel Drug Delivery Systems Revenue by Country 56
    • 9.1.2 Brazil 58
    • 9.1.3 Argentina 59
  • 9.2 South America Novel Drug Delivery Systems by Type 59
  • 9.3 South America Novel Drug Delivery Systems by Application 61

10 Middle East and Africa 63

  • 10.1 Middle East and Africa Novel Drug Delivery Systems by Country 63
    • 10.1.1 Middle East and Africa Novel Drug Delivery Systems Revenue by Country 63
    • 10.1.1 Middle East 65
    • 10.1.2 Africa 66
  • 10.2 Middle East and Africa Novel Drug Delivery Systems by Type 66
  • 10.3 Middle East and Africa Novel Drug Delivery Systems by Application 68

11 Analysis of Novel Drug Delivery Systems Industry Key Manufacturers 70

  • 11.1 Amgen 70
    • 11.1.1 Company Profile 70
    • 11.1.2 Product Information 71
    • 11.1.3 Revenue, Gross Margin and Market Share 71
  • 11.2 Teva 72
    • 11.2.1 Company Profile 72
    • 11.2.2 Product Information 73
    • 11.2.3 Revenue, Gross Margin and Market Share 73
  • 11.3 Roche 74
    • 11.3.1 Company Profile 74
    • 11.3.2 Product Information 75
    • 11.3.3 Revenue, Gross Margin and Market Share 76
  • 11.4 UCB (Union Chimique Belge) 76
    • 11.4.1 Company Profile 76
    • 11.4.2 Product Information 77
    • 11.4.3 Revenue, Gross Margin and Market Share 78
  • 11.5 Celgene 78
    • 11.5.1 Company Profile 78
    • 11.5.2 Product Information 80
    • 11.5.3 Revenue, Gross Margin and Market Share 80
  • 11.6 Merck 81
    • 11.6.1 Company Profile 81
    • 11.6.2 Product Information 82
    • 11.6.3 Revenue, Gross Margin and Market Share 82
  • 11.7 Gilead Sciences 83
    • 11.7.1 Company Profile 83
    • 11.7.2 Product Information 84
    • 11.7.3 Revenue, Gross Margin and Market Share 84
  • 11.8 Sanofi 84
    • 11.8.1 Company Profile 84
    • 11.8.2 Product Information 86
    • 11.8.3 Revenue, Gross Margin and Market Share 86
  • 11.9 Pfizer 86
    • 11.9.1 Company Profile 86
    • 11.9.2 Product Information 88
    • 11.9.3 Revenue, Gross Margin and Market Share 88
  • 11.10 Takeda 89
    • 11.10.1 Company Profile 89
    • 11.10.2 Product Information 90
    • 11.10.3 Revenue, Gross Margin and Market Share 90
  • 11.11 Bausch&Lomb 91
    • 11.11.1 Company Profile 91
    • 11.11.2 Product Information 92
    • 11.11.3 Revenue, Gross Margin and Market Share 92
  • 11.12 Samyang Biopharmaceuticals 93
    • 11.12.1 Company Profile 93
    • 11.12.2 Product Information 94
    • 11.12.3 Revenue, Gross Margin and Market Share 94
  • 11.13 Johnson & Johnson 94
    • 11.13.1 Company Profile 94
    • 11.13.2 Product Information 96
    • 11.13.3 Revenue, Gross Margin and Market Share 96
  • 11.14 TOLMAR 97
    • 11.14.1 Company Profile 97
    • 11.14.2 Product Information 98
    • 11.14.3 Revenue, Gross Margin and Market Share 98
  • 11.15 Astellas 99
    • 11.15.1 Company Profile 99
    • 11.15.2 Product Information 100
    • 11.15.3 Revenue, Gross Margin and Market Share 100
  • 11.16 AMAG Pharmaceuticals 101
    • 11.16.1 Company Profile 101
    • 11.16.2 Product Information 102
    • 11.16.3 Revenue, Gross Margin and Market Share 102
  • 11.17 AbbVie 103
    • 11.17.1 Company Profile 103
    • 11.17.2 Product Information 104
    • 11.17.3 Revenue, Gross Margin and Market Share 104
  • 11.18 Dr Reddy 105
    • 11.18.1 Company Profile 105
    • 11.18.2 Product Information 106
    • 11.18.3 Revenue, Gross Margin and Market Share 106
  • 11.19 AstraZeneca 107
    • 11.19.1 Company Profile 107
    • 11.19.2 Product Information 108
    • 11.19.3 Revenue, Gross Margin and Market Share 108
  • 11.20 Aspen 109
    • 11.20.1 Company Profile 109
    • 11.20.2 Product Information 110
    • 11.20.3 Revenue, Gross Margin and Market Share 110
  • 11.21 Acrotech Biopharma 111
    • 11.21.1 Company Profile 111
    • 11.21.2 Product Information 112
    • 11.21.3 Revenue, Gross Margin and Market Share 113
  • 11.22 TWi Pharmaceuticals 113
    • 11.22.1 Company Profile 113
    • 11.22.2 Product Information 114
    • 11.22.3 Revenue, Gross Margin and Market Share 114

12 Future Forecast 115

  • 12.1 Novel Drug Delivery Systems Market Forecast by Region 115
  • 12.2 Novel Drug Delivery Systems Market Forecast by Type 115
  • 12.3 Novel Drug Delivery Systems Market Forecast by Application 116
  • 12.4 North America Novel Drug Delivery Systems Forecast 117
  • 12.5 Europe Novel Drug Delivery Systems Forecast 118
  • 12.6 Asia Pacific Novel Drug Delivery Systems Forecast 119
  • 12.7 South America Novel Drug Delivery Systems Forecast 120
  • 12.8 Middle East and Africa Novel Drug Delivery Systems Forecast 121

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 122

  • 13.1 Market Opportunities and Drivers 122
  • 13.2 Market Challenges 123
  • 13.3 Market Risks/Restraints 123
  • 13.4 Porter's Five Forces Analysis 125

14 Value Chain and Sales Channels Analysis 127

  • 14.1 Value Chain Analysis 127
  • 14.2 Novel Drug Delivery Systems Customers 128
  • 14.3 Sales Channels Analysis 130
    • 14.3.1 Sales Channels 130
    • 14.3.2 Distributors 131

15 Research Findings and Conclusion 134

16 Appendix 135

  • 16.1 Research Methodology 135
    • 16.1.1 Methodology/Research Approach 135
      • 16.1.1.1 Research Programs/Design 135
      • 16.1.1.2 Market Size Estimation 136
      • 16.1.1.3 Market Breakdown and Data Triangulation 137
    • 16.1.2 Data Source 139
      • 16.1.2.1 Secondary Sources 139
      • 16.1.2.2 Primary Sources 140
  • 16.2 Author Details 141
  • 16.3 Disclaimer 141
  • Figure Novel Drug Delivery Systems Product Picture 1
  • Table Novel Drug Delivery Systems Market Segments 2
  • Table Key Manufacturers of Novel Drug Delivery Systems Covered in 2018 3
  • Table Global Novel Drug Delivery Systems Market Size Growth Rate by Type (2019-2025) (Million US$) 4
  • Figure Global Novel Drug Delivery Systems Market Share by Type in 2018 5
  • Figure Global Novel Drug Delivery Systems Market Share by Type in 2025 5
  • Figure Liposomes Product Picture 6
  • Figure PEGylated Proteins & Polypeptides Product Picture 6
  • Figure Polymer Nanoparticle Product Picture 7
  • Figure Protein-drug Conjugates Product Picture 7
  • Table Global Novel Drug Delivery Systems Market Size Growth Rate by Application (2019-2025) (Million US$) 8
  • Figure Global Novel Drug Delivery Systems Market Share by Application in 2018 9
  • Figure Global Novel Drug Delivery Systems Market Share by Application in 2025 9
  • Figure Hospitals & Clinic 10
  • Figure Cancer Treatment Centers 10
  • Figure Novel Drug Delivery Systems Report Years Considered 12
  • Figure Global Novel Drug Delivery Systems Market Size 2014-2025 (Million US$) 13
  • Table Global Novel Drug Delivery Systems Market Size by Region 2019-2025 (Million US$) 14
  • Figure Global Novel Drug Delivery Systems Market Share by Regions in 2018 14
  • Table Global Novel Drug Delivery Systems Revenue by Region 2014-2019 (Million US$) 15
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Region 2014-2019 15
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Region in 2018 16
  • Table Novel Drug Delivery Systems Revenue by Manufacturer (2018-2019) (Million USD) 17
  • Table Novel Drug Delivery Systems Revenue Share by Manufacturer (2018-2019) 18
  • Figure Novel Drug Delivery Systems Revenue Share by Manufacturer in 2018 19
  • Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 20
  • Table Key Manufacturers Novel Drug Delivery Systems Gross Margin (2018-2019) 20
  • Table Novel Drug Delivery Systems Manufacturers Headquarters and Established Date 21
  • Table Manufacturers Novel Drug Delivery Systems Product Type 22
  • Table Manufacturers Mergers & Acquisitions, Expansion Plans 23
  • Table Global Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 25
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 25
  • Figure Global Novel Drug Delivery Systems Revenue Market Share by Type in 2018 26
  • Table Global Novel Drug Delivery Systems Market Size Growth Rate by Application (2019-2025) (Million US$) 27
  • Table Global Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 27
  • Table Global Novel Drug Delivery Systems Revenue Share by Application (2014-2019) 27
  • Figure Global Novel Drug Delivery Systems Market Revenue by Application (2014-2019) 28
  • Figure Global Novel Drug Delivery Systems Market Share by Application in 2018 28
  • Figure North America Novel Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$) 29
  • Table North America Novel Drug Delivery Systems Revenue by Country (2014-2019) (Million US$) 29
  • Table North America Novel Drug Delivery Systems Revenue Market Share by Country (2014-2019) 30
  • Figure North America Novel Drug Delivery Systems Revenue Market Share by Country in 2018 30
  • Figure United States Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 31
  • Figure Canada Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 32
  • Figure Mexico Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 33
  • Table North America Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 33
  • Table North America Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 34
  • Figure North America Novel Drug Delivery Systems Market Share by Type in 2018 34
  • Table North America Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 35
  • Table North America Novel Drug Delivery Systems Revenue Market Share by Application (2014-2019) 35
  • Figure North America Novel Drug Delivery Systems Market Share by Application in 2018 36
  • Figure Europe Novel Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$) 37
  • Table Europe Novel Drug Delivery Systems Revenue by Country (2014-2019) (Million US$) 37
  • Table Europe Novel Drug Delivery Systems Revenue Market Share by Country (2014-2019) 38
  • Figure Europe Novel Drug Delivery Systems Revenue Market Share by Country in 2018 38
  • Figure Germany Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 39
  • Figure France Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 40
  • Figure UK Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 41
  • Figure Italy Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 42
  • Figure Russia Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 43
  • Table Europe Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 43
  • Table Europe Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 44
  • Figure Europe Novel Drug Delivery Systems Market Share by Type in 2018 44
  • Table Europe Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 45
  • Table Europe Novel Drug Delivery Systems Revenue Market Share by Application (2014-2019) 45
  • Figure Europe Novel Drug Delivery Systems Market Share by Application in 2018 46
  • Figure Asia Pacific Novel Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$) 47
  • Table Asia Pacific Novel Drug Delivery Systems Revenue by Country (2014-2019) (Million US$) 47
  • Table Asia Pacific Novel Drug Delivery Systems Revenue Market Share by Country (2014-2019) 48
  • Figure Asia Pacific Novel Drug Delivery Systems Revenue Market Share by Country in 2018 48
  • Figure China Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 49
  • Figure Japan Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 50
  • Figure Korea Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 51
  • Figure India Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 52
  • Figure Southeast Asia Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 53
  • Table Asia Pacific Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 53
  • Table Asia Pacific Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 54
  • Figure Asia Pacific Novel Drug Delivery Systems Market Share by Type in 2018 54
  • Table Asia Pacific Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 54
  • Table Asia Pacific Novel Drug Delivery Systems Revenue Market Share by Application (2014-2019) 55
  • Figure Asia Pacific Novel Drug Delivery Systems Market Share by Application in 2018 55
  • Figure South America Novel Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$) 56
  • Table South America Novel Drug Delivery Systems Revenue by Country (2014-2019) (Million US$) 56
  • Table South America Novel Drug Delivery Systems Revenue Market Share by Country (2014-2019) 57
  • Figure South America Novel Drug Delivery Systems Revenue Market Share by Country in 2018 57
  • Figure Brazil Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 58
  • Figure Argentina Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 59
  • Table South America Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 59
  • Table South America Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 60
  • Figure South America Novel Drug Delivery Systems Market Share by Type in 2018 60
  • Table South America Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 61
  • Table South America Novel Drug Delivery Systems Revenue Market Share by Application (2014-2019) 61
  • Figure South America Novel Drug Delivery Systems Market Share by Application in 2018 62
  • Figure Middle East and Africa Novel Drug Delivery Systems Revenue Growth Rate 2014-2019 (Million US$) 63
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue by Country (2014-2019) (Million US$) 63
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Country (2014-2019) 64
  • Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Country in 2018 64
  • Figure Middle East Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 65
  • Figure Africa Novel Drug Delivery Systems Revenue Growth Rate (2014-2019) (Million US$) 66
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue by Type (2014-2019) (Million US$) 66
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Type (2014-2019) 67
  • Figure Middle East and Africa Novel Drug Delivery Systems Market Share by Type in 2018 67
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue by Application (2014-2019) (Million US$) 68
  • Table Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Application (2014-2019) 68
  • Figure Middle East and Africa Novel Drug Delivery Systems Market Share by Application in 2018 69
  • Table Amgen Company Profile 70
  • Figure Novel Drug Delivery Systems Product Picture of Amgen 71
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Amgen 2018-2019 71
  • Table Teva Company Profile 72
  • Figure Novel Drug Delivery Systems Product Picture of Teva 73
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Teva 2018-2019 73
  • Table Roche Company Profile 74
  • Figure Novel Drug Delivery Systems Product Picture of Roche 75
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Roche 2018-2019 76
  • Table UCB (Union Chimique Belge) Company Profile 76
  • Figure Novel Drug Delivery Systems Product Picture of UCB (Union Chimique Belge) 77
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of UCB (Union Chimique Belge) 2018-2019 78
  • Table Celgene Company Profile 78
  • Figure Novel Drug Delivery Systems Product Picture of Celgene 80
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Celgene 2018-2019 80
  • Table Merck Company Profile 81
  • Figure Novel Drug Delivery Systems Product Picture of Merck 82
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Merck 2018-2019 82
  • Table Gilead Sciences Company Profile 83
  • Figure Novel Drug Delivery Systems Product Picture of Gilead Sciences 84
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Gilead Sciences 2018-2019 84
  • Table Sanofi Company Profile 84
  • Figure Novel Drug Delivery Systems Product Picture of Sanofi 86
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Sanofi 2018-2019 86
  • Table Pfizer Company Profile 86
  • Figure Novel Drug Delivery Systems Product Picture of Pfizer 88
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Pfizer 2018-2019 88
  • Table Takeda Company Profile 89
  • Figure Novel Drug Delivery Systems Product Picture of Takeda 90
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Takeda 2018-2019 90
  • Table Bausch&Lomb Company Profile 91
  • Figure Novel Drug Delivery Systems Product Picture of Bausch&Lomb 92
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Bausch&Lomb 2018-2019 92
  • Table Samyang Biopharmaceuticals Company Profile 93
  • Figure Novel Drug Delivery Systems Product Picture of Samyang Biopharmaceuticals 94
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Samyang Biopharmaceuticals 2018-2019 94
  • Table Johnson & Johnson Company Profile 94
  • Figure Novel Drug Delivery Systems Product Picture of Johnson & Johnson 96
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Johnson & Johnson 2018-2019 96
  • Table TOLMAR Company Profile 97
  • Figure Novel Drug Delivery Systems Product Picture of TOLMAR 98
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of TOLMAR 2018-2019 98
  • Table Astellas Company Profile 99
  • Figure Novel Drug Delivery Systems Product Picture of Astellas 100
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Astellas 2018-2019 100
  • Table AMAG Pharmaceuticals Company Profile 101
  • Figure Novel Drug Delivery Systems Product Picture of AMAG Pharmaceuticals 102
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of AMAG Pharmaceuticals 2018-2019 102
  • Table AbbVie Company Profile 103
  • Figure Novel Drug Delivery Systems Product Picture of AbbVie 104
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of AbbVie 2018-2019 104
  • Table Dr Reddy Company Profile 105
  • Figure Novel Drug Delivery Systems Product Picture of Dr Reddy 106
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Dr Reddy 2018-2019 106
  • Table AstraZeneca Company Profile 107
  • Figure Novel Drug Delivery Systems Product Picture of AstraZeneca 108
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of AstraZeneca 2018-2019 108
  • Table Aspen Company Profile 109
  • Figure Novel Drug Delivery Systems Product Picture of Aspen 110
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Aspen 2018-2019 110
  • Table Acrotech Biopharma Company Profile 111
  • Figure Novel Drug Delivery Systems Product Picture of Acrotech Biopharma 112
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of Acrotech Biopharma 2018-2019 113
  • Table TWi Pharmaceuticals Company Profile 113
  • Figure Novel Drug Delivery Systems Product Picture of TWi Pharmaceuticals 114
  • Table Novel Drug Delivery SystemsRevenue (M USD) and Gross Margin of TWi Pharmaceuticals 2018-2019 114
  • Table Global Novel Drug Delivery Systems Revenue Forecast by Region 2020-2025 (Million US$) 115
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Region 2020-2025 115
  • Table Global Novel Drug Delivery Systems Revenue Forecast by Type (2020-2025) (Million US$) 115
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Type (2020-2025) 116
  • Table Global Novel Drug Delivery Systems Revenue Forecast by Application (2020-2025) (Million US$) 116
  • Table Global Novel Drug Delivery Systems Revenue Market Share Forecast by Application (2020-2025) 116
  • Figure North America Novel Drug Delivery Systems Revenue Growth Rate Forecast (2020-2025) (Million US$) 117
  • Figure Europe Novel Drug Delivery Systems Revenue Growth Rate Forecast (2020-2025) (Million US$) 118
  • Figure Asia Pacific Novel Drug Delivery Systems Revenue Growth Rate Forecast (2020-2025) (Million US$) 119
  • Figure South America Novel Drug Delivery Systems Revenue Growth Rate Forecast (2020-2025) (Million US$) 120
  • Figure Middle East and Africa Novel Drug Delivery Systems Revenue Growth Rate Forecast (2020-2025) (Million US$) 121
  • Table Key Opportunities and Drivers: Impact Analysis (2019-2025) 123
  • Table Key Challenges 123
  • Figure Types of Drug Delivery 124
  • Figure Porter's Five Forces Analysis 126
  • Figure Novel Drug Delivery Systems Value Chain 127
  • Table Novel Drug Delivery Systems Customers List 128
  • Figure Channels of Distribution 131
  • Table Novel Drug Delivery Systems Distributors List 131
  • Figure Distributors Profiles 133
  • Table Research Programs/Design for This Report 135
  • Figure Bottom-up and Top-down Approaches for This Report 137
  • Figure Data Triangulation 138
  • Figure Key Executives Interviewed 139
  • Table Key Data Information from Secondary Sources 140
  • Table Key Data Information from Primary Sources 140
Back to Top